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Abstract
Background: The aim of the present study was to examine how lipid profiles are associated with insulin resistance
in Japanese community-dwelling adults.
Methods: This cross-sectional study included 614 men aged 58 ± 14 (mean ± standard deviation; range, 20-89)
years and 779 women aged 60 ± 12 (range, 21-88) years. The study sample were 1,042 (74.8%) non-obese (BMI <
25.0 kg/m
2) and 351 (25.2%) overweight (BMI ≥ 25 kg/m
2) subjects. Insulin resistance was defined by homeostasis
model assessment of insulin resistance (HOMA-IR) of at least 2.5. The areas under the curve (AUC) of the receiver
operating characteristic curves (ROC) were used to compare the power of these serum markers.
Results: In non-obese subjects, the best marker of insulin resistance was low-density lipoprotein cholesterol (LDL-
C)/high-density lipoprotein cholesterol (HDL-C) ratio of 0.74 (95% confidence interval (CI), 0.66-0.80). The HDL-C,
triglyceride (TG)/HDL-C ratio, and non-HDL-C also discriminated insulin resistance, as the values for AUC were 0.31
(95% CI, 0.24-0.38), 0.69 (95% CI, 0.62-0.75) and 0.69 (95% CI, 0.62-0.75), respectively. In overweight subjects, the
AUC for TG and TG/HDL-C ratio were 0.64 (0.58-0.71) and 0.64 (0.57-0.70), respectively. The optimal cut-off point to
identifying insulin resistance for these markers yielded the following values: TG/HDL-C ratio of ≥1.50 and LDL-C/
HDL-C ratio of ≥2.14 in non-obese subjects, and ≥2.20, ≥2.25 in overweight subjects. In non-obese subjects, the
positive likelihood ratio was greatest for LDL-C/HDL-C ratio.
Conclusion: In non-obese Japanese adults, LDL-C/HDL-C ratio may be the best reliable marker of insulin resistance.
Background
Being overweight is also a major worldwide public
health problem. In Japanese adults, it was demonstrated
that 29.3% of men and 19.5% of women are overweight
(body mass index (BMI); weight (kg)/height (m)
2, ≥25
kg/m
2), with approximately 3.3% of men and 3.2% of
women designated as obese (BMI ≥ 30 kg/m
2)[ 1 ] .
Several large-scale studies have shown that overweight
people, defined on the basis of a high BMI, increases
the risk of hypertension, dyslipidemia, diabetes and
developing cardiovascular disease (CVD) such as stroke
and myocardial infarction than subjects with normal
BMI [2-4]. Moreover, it has been suggested that indivi-
duals exist who are not overweight, but who, like peo-
ple with overt obesity, also have hyperinsulinemia, are
insulin resistant, and are predisposed to hypertriglycer-
idemia, type 2 diabetes mellitus, and premature cardio-
vascular disease [5,6]. Much investigation has been
focused on insulin resistance as the primary determi-
nant of atherosclerotic risk factors, independent of
BMI [7].
On the other hand, insulin resistant persons also have
a characteristic dyslipidemia [8] and measuring these
variables might help identify insulin resistance. Plasma
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C) [9,10], and total cholesterol (T-C)/HDL-C are inde-
pendently associated with insulin resistance and risk
factors of CVD [11]. However, in Japanese community-
dwelling persons, there are few studies to demonstrate a
relationship between lipid profiles and insulin resistance,
categorized by BMI.
We took advantage of the large representative sample
of Japanese adults who participated at the time of their
annual health examination. We investigated how lipid
profiles were associated with insulin resistance in
healthy Japanese adults. For this, we used cross-sectional
data from community-dwelling participants without
clinical diabetes.
Methods
Subjects
Participants were recruited at the time of their annual
health examination in a rural town with a total popula-
tion of 11,136 (as of April 2002) and located in Ehime
prefecture, Japan, in 2002. Among the 9,133 adults (4,395
of them male) aged 19 to 90 years in this population, a
random sample of 3,164 subjects (34.6%) was recruited.
Information on medical history, present conditions, and
drugs was obtained by interview. Other characteristics,
e.g., smoking and alcohol habits, and medication, were
investigated by individual interviews using a structured
questionnaire. Subjects taking medications for hyperten-
sion, diabetes, or dyslipidemia were excluded. The final
study sample included 614 men and 779 women. This
study was approved by the ethics committee of Ehime
University School of Medicine, and written informed
consent was obtained from each subject.
Evaluation of confounding factors
Information on demographic characteristics and risk
factors was collected using clinical files. Body mass
index was calculated by dividing weight (in kilograms)
by the square of the height (in meters). We measured
blood pressure in the right upper arm of participants in
a sedentary position using an automatic oscillometric
blood pressure recorder (BP-103i; Colin, Aichi, Japan)
while the subjects were seated after having rested for at
least 5 min. Smoking status was defined as the number
of cigarette packs per day multiplied by the number of
years smoked (pack·year), and the participants were clas-
sified into never smokers, past smokers, light smokers
(<30 pack·year) and heavy smokers (≥30 pack·year). The
daily alcohol consumption was measured using the Japa-
nese liquor unit in which a unit corresponds to 22.9 g
of ethanol, and the participants were classified into
never drinkers, occasional drinkers (<1 unit/day), light
drinkers (1-1.9 unit/day), and heavy drinkers (≥2u n i t /
day). T-C, TG, HDL-C, fasting blood glucose (FBG),
creatinine (enzymatic method), uric acid, and immunor-
eactive insulin (IRI), and high molecular weight (HMW)
adiponectin (FUJIREBIO, Tokyo, Japan) were measured
during fasting low-density lipoprotein cholesterol (LDL-
C) levels were calculated using the Friedewald formula
[12]. Participants with TG levels ≥400 mg/dl were
excluded. Homeostasis of minimal assessment of insulin
resistance (HOMA-IR) was calculated from FBG and IRI
levels using the following formula; {FBG (mg/dL) × IRI
(mU/mL)}/405 [13], and a borderline level of Insulin
resistance was defined as HOMA-IR ≥ 1.6 [13], and a
definite level, HOMA-IR ≥ 2.5 [14].
Statistical analysis
Statistical analysis was performed using PASW Statistics
17.0 (Statistical Package for Social Science Japan, Inc.,
Tokyo, Japan). All values are expressed as mean ± stan-
dard deviation (SD), unless otherwise specified. Data for
T G ,F B G ,H O M A - I R ,a n ds e r u mH M Wa d i p o n e c t i n
were skewed, and log-transformed for analysis. Subjects
were divided into two groups based on BMI (non-obese,
<25.0 kg/m
2;o v e r w e i g h t ,≥25.0 kg/m
2), and differences
between the two groups were determined by Student’s
t-test andc
2 test. In addition, areas under the receiver
operating characteristic (ROC) curves were determined
for each variable to identify the predictors of insulin
resistance. Areas under the ROC curves are provided
with standard errors. An ROC curve is a plot of the sen-
sitivity (true positive) versus 1-specificity (false positive)
for each potential marker tested. The area under the
ROC curve is a summary of the overall diagnostic accu-
racy of the test. The best markers have ROC curves that
are shifted to the left with areas under the curve near
unity. Nondiagnostic markers are represented by diago-
nals with areas under the ROC curves close to 0.5.
Likelihood ratios were calculated as the ratios of sensi-
tivity - (1 - specificity) (positive likelihood ratio) and
(1 - sensitivity) - specificity (negative likelihood ratio).
A value of P < 0.05 was considered significant.
Results
Background factors of subjects categorized by BMI
Table 1 shows the value of each background factor cate-
gorized by BMI. The subjects comprised 614 men aged
58 ± 14 (mean ± standard deviation; range, 20-89) years
and 779 women aged 60 ± 12 (range, 21-88) years. The
mean BMI in the study sample was 23.1 ± 3.1 kg/m
2,
with 1,042 non-obese (BMI < 25.0 kg/m
2)( 7 4 . 8 % )a n d
351 overweight (BMI ≥ 25 kg/m
2) (25.2%). Alcohol con-
sumption, systolic blood pressure (SBP), diastolic blood
pressure (DBP), T-C, TG, LDL-C, TG/HDL-C ratio,
non-HDL-C, LDL-C/HDL-C ratio, and uric acid were
significantly higher in subjects with a BMI ≥ 25.0 kg/m
2,
but age, HDL-C and serum HMW adiponectin were
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group differences in sex, smoking status, eGFR, and pre-
valence of CVD.
Insulin resistance of subjects categorized by BMI
Fasting blood glucose, IRI, and HOMA-IR were signifi-
cantly higher in overweight subjects (Table 2), and pre-
valence of insulin resistance (HOMA-IR > 1.6 or >2.5)
was significantly higher in overweight subjects than in
non-obese subjects.
Comparison of areas under ROC curves (95% CI) for
potential markers of insulin resistance of subjects
categorized by BMI
In non-obese subjects, the ROC curve analyses showed
that the best marker of insulin resistance was LDL-C/
HDL-C ratio, with an area under the ROC curve of 0.74
(0.66-0.80) (Table 3; Figure 1). The TG/HDL-C ratio,
HDL-C, and non-HDL-C also discriminated insulin
resistance, as they had areas under the ROC curve of
0.31 (0.24-0.38), 0.69 (0.62-0.75) and 0.69 (0.62-0.75),
respectively. In overweight subjects, TG and TG/HDL-C
ratio were more effective.
Optimal cut-off point of TG/HDL-C ratio and LDL-C/HDL-C
ratio for predicting insulin resistance of subjects
categorized by BMI
Table 4 shows the cut-off points of TG/HDL-C ratio
and LDL-C/HDL-C ratio for identifying insulin resis-
tance. The optimal cut-off point to identifying insulin
resistance for these markers yielded the following values:
TG/HDL-C ratio of ≥1.50 and LDL-C/HDL-C ratio of
Table 1 Characteristics of subjects categorized by body mass index
Total Non-obese Overweight
Body mass index†
Characteristics
All
N = 1,393
<25.0 kg/m
2
N = 1,042
≥25.0 kg/m
2
N = 351
P -value*
Male sex, % 44.1 43.3 46.4 0.320
Age (years) 59 ± 13 60 ± 13 57 ± 12 0.006
Body mass index (kg/m
2) 23.1 ± 3.1 21.7 ± 2.0 27.1 ± 2.2 <0.001
Smoking status {never/ex/light/heavy (%)} 71.0/9.6/9.0/10.4 72.3/8.4/8.8/10.5 67.2/13.1/9.4/10.3 0.073
Alcohol consumption {never/light/moderate/heavy(%)} 39.0/31.7/18.6/10.8 40.7/30.3/19.0/10.0 33.9/35.6/17.4/13.1 0.043
Systolic blood pressure (mmHg) 133 ± 21 132 ± 21 139 ± 19 <0.001
Diastolic blood pressure (mmHg) 80 ± 11 79 ± 11 83 ± 11 <0.001
Total cholesterol (mg/dL) 201 ± 35 200 ± 34 204 ± 35 0.031
Triglycerides (mg/dL) 90 (68-127) 85 (64-117) 108 (81-153) <0.001
HDL cholesterol (mg/dL) 62 ± 15 64 ± 16 57 ± 13 <0.001
LDL cholesterol (mg/dL) 118 ± 31 116 ± 31 123 ± 32 <0.001
Triglycerides/HDL cholesterol ratio 1.5 (1.0-2.3) 1.3 (0.9-2.0) 1.9 (1.3-3.2) 0.001
Non-HDL cholesterol (mg/dL) 139 ± 34 135 ± 34 148 ± 34 <0.001
LDL-cholesterol/HDL-cholesterol ratio 2.01 ± 0.78 1.92 ± 0.74 2.30 ± 0.82 <0.001
Uric acid (mg/dL) 5.0 ± 1.4 4.8 ± 1.4 5.5 ± 1.4 <0.001
eGFR 83.3 ± 16.4 83.4 ± 16.1 82.9 ± 17.2 0.659
Serum HMW adiponectin (μg/mL) 3.0 (4.9-8.0) 5.4 (3.2-8.7) 3.9 (2.2-5.8) <0.001
Cardiovascular disease, % 4.7 4.8 4.3 0.771
HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; HMW, high molecular weight. Data presented are mean ±
standard deviation. Data for triglycerides, TG/HDL-C ratio, and serum adiponectin were skewed, and are presented as median (interquartile range). Data for
triglycerides, TG/HDL-C ratio, and serum adiponectin were log-transformed for analysis. * Student’s t-test or c
2 test.
Table 2 Insulin resistance of subjects categorized by body mass index
Total Non-obese Overweight
Body mass index
Characteristics
All
N = 1,393
<25.0 kg/m
2
N = 1,042
≥25.0 kg/m
2
N = 351
P -value*
Fasting blood glucose (mg/dL) 92 (87-99) 91 (86-98) 95 (89-103) <0.001
Immunoreactive insulin (mU/mL) 5.1 (3.4-7.6) 4.5 (3.0-6.5) 8.0 (5.3-11.2) <0.001
HOMA-IR§ 1.19 (0.75-1.83) 1.02 (0.65-1.52) 1.91 (1.23-2.81) <0.001
HOMA-IR§ ≤ 1.6, % 68.1 77.9 39.0
HOMA-IR§ > 1.6 and ≤2.5, % 19.8 16.1 30.8 <0.001
HOMA-IR§ > 2.5, % 12.1 6.0 30.2 <0.001
HOMA-IR, homeostasis of minimal assessment of insulin resistance. Data for fasting blood glucose, fasting insulin, and HOMA-IR were skewed, and are presented
as median (interquartile range). §HOMA-IR was calculated using the following formula; {fasting blood glucose (FBG) (mg/dL) X fasting Immunoreactive insulin
(mU/mL)}/405. Data for fasting blood glucose, fasting insulin, and HOMA-IR were log-transformed for analysis. *Student’s t test or c
2 test.
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weight. In non-obese subjects, the positive likelihood
ratio value indicates that the odds of insulin resistance
increased by 2.30-fold if the LDL-C/HDL-C ratio was
positive (the value ≥2.14). This ratio was greater for
LDL-C/HDL-C ratio than TG/HDL-C ratio. The nega-
tive likelihood ratios indicate the extent to which the
odds of insulin resistance decrease if the test is negative.
These odds also decreased more so for LDL-C/HDL-C
ratio. In overweight subjects, these values were similar.
Discussion
In the present study, we examined whether lipid profiles
( i . e . ,T G ,H D L - C ,L D L - C ,T G / H D L - Cr a t i o ,L D L - C /
HDL-C ratio and non-HDL-C) were associated with
insulin resistance in Japanese adults, categorized by
body mass index. Most fundamental is the fact that not
all overweight or obese persons are insulin resistant. In
non-obese subjects, 6.0% of them were insulin resistant,
and the best marker of insulin resistance was LDL-C/
HDL-C ratio, but HDL-C, TG/HDL-C ratio and non-
HDL-C also discriminated insulin resistance. In over-
weight subjects, the areas of TG and TG/HDL-C ratio
were greater than those of the other parameters. The
optimal cut-off point to identifying insulin resistance for
these markers yielded the following values: TG/HDL-C
ratio of ≥1.50 and LDL-C/HDL-C ratio of ≥2.14 in non-
obese subjects, and ≥2.20 and ≥2.25, respectively in
Table 3 Comparison of areas under the ROC curves (95% CI) for potential markers of insulin resistance
(HOMA-IR§ > 2.5) of subjects categorized by body mass index
AUC (95% CI)
Total Non-obese Overweight
Body mass index
Characteristics
All
N = 1,393
P-value <25.0 kg/m
2
N = 1,042
P-value >25.0 kg/m
2
N = 351
P-value
Triglycerides (mg/dL) 0.69 (0.45-0.73) <0.001 0.66 (0.59-0.72) <0.001 0.64 (0.58-0.71) <0.001
HDL cholesterol (mg/dL) 0.33 (0.28-0.37) <0.001 0.31 (0.24-0.38) <0.001 0.41 (0.35-0.48) 0.009
LDL cholesterol (mg/dL) 0.61 (0.56-0.65) <0.001 0.65 (0.58-0.72) <0.001 0.54 (0.48-0.61) 0.188
Triglycerides/HDL cholesterol ratio 0.70 (0.66-0.75) <0.001 0.69 (0.62-0.75) <0.001 0.64 (0.57-0.70) <0.001
Non-HDL cholesterol (mg/dL) 0.66 (0.61-0.70) <0.001 0.69 (0.62-0.75) <0.001 0.59 (0.52-0.65) 0.011
LDL-cholesterol/HDL-cholesterol ratio 0.69 (0.65-0.73) <0.001 0.74 (0.66-0.80) <0.001 0.58 (0.51-0.65) 0.021
ROC, receiver operating characteristics; HOMA-IR, homeostasis of minimal assessment of insulin resistance; CI, confidence interval; AUC, area under ROC curve;
HDL, high-density lipoprotein; LDL, low-density lipoprotein. §HOMA-IR was calculated using the following formula; {fasting blood glucose (mg/dL) X immuno-
reactive insulin (mU/mL)}/405.
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Figure 1 Receiver operating characteristics (ROC) curves. Sensitivity represents the true-positive results and 1-specificity, the false-positive
results. The best markers have ROC curves that are shifted to the left with areas under the curve near unity. Nondiagnostic markers are
represented by diagonals with areas under the ROC curves close to 0.5.
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LDL-C/HDL-C ratio in non-obese subjects. Lipid ratio
of LDL-C/HDL-C might be used as an integrated and
simple lipid measure to evaluate insulin resistance in
non-obese subjects.
Resistance to insulin-mediated glucose disposal is dis-
tributed continuously through the general population [15],
and we have no criterion with which to identify a partici-
pant as being insulin resistance or insulin sensitive. How-
ever, we classified a participant as insulin resistant if he or
she was in HOMA-IR > 2.5 [14]. Previous studies have
shown that HOMAIR-based insulin resistance scores
strongly correlate with glucose clamp-assessed insulin
resistance [13,15]. However, the validation was carried out
in only a few subjects, and HOMA-IR is less accurate and
precise than the glucose clamp in measuring insulin resis-
tance, but this limitation is mitigated when the number of
subjects examined is large, as in our study [16].
Hypertriglyceridemia and low HDL-C almost never
occurred as isolated disorders, and were nearly always
associated with insulin resistance because insulin affects
very low-density lipoprotein and HDL-C metabolism
[17]. In previous studies, several lipid ratios have been
proposed as simple and useful clinical indicators of insu-
lin resistance. The TG/HDL-C, the T-C/HDL-C, and the
LDL-C/HDL-C ratio have shown similar potential for
insulin resistance, though the reports are not entirely
consistent. In 50 white Americans, both TG and TG/
HDL-C ratio were acceptable markers for insulin resis-
tance, with area under the ROC curve of 0.763 and
0.770, respectively, but poor predictors in 99 African
Americans, with the values at 0.625 and 0.639, respec-
tively [18]. It was demonstrated that the relationship
between TG and TG/HDL-C with insulin resistance dif-
fers by ethnicity. In 3,014 patients (mean age 54 years;
55% women), TG/HDL-C ratio and T-C/HDL-C ratio
were related to insulin resistance assessed by the top
quartile of the HOMA-IR, and the area under the ROC
curves for predicting insulin resistance with TG/HDL-C
ratio and T-C/HDL-C ratio were 0.745 and 0.707,
respectively [19]. LDL-C/HDL-C ratio [20] as well as
TG/HDL-C ratio [21] have advantages for standardiza-
tion and identification of patients with an atherogenic
lipoprotein profile as a surrogate maker of insulin resis-
tance. Also in our study, both LDL-C/HDL-C and TG/
HDL-C ratio were useful makers of insulin resistance,
especially in all subjects or non-obese subjects. However,
these makers were weaker in overweight subjects. Kimm
et al. [21] demonstrated that the lipid ratios of TC/
HDL-C, LDL-C/HDL-C and TG/HDL-C, as well as TG
and HDL-C, were consistently associated with metabolic
syndrome and insulin resistance in participants without
metabolic syndrome, though these relations were weaker
in participants with metabolic syndrome. Lipid ratios
that include information on at least two measures might
have a more integrated explanation than single lipid
measures such as TG or HDL-C [21].
Some limitations of this study must be considered.
First, the response rate was as low as 35% that is usually
the casein other conventional community studies in
Japan. However, the relatively large sample size enabled
the assessment of an extensive array of insulin resis-
tances in relation to lipid profiles. Second, the cross-
sectional study design is limited in its ability to
eliminate causal relationships between lipid profiles and
HOMA-IR. Third, our definition of HOMA-IR is based
on a single assessment of FBS and IRI, which may intro-
duce misclassification bias. Therefore the demographics
and referral source may limit generalizability.
In conclusion, the present study demonstrated that
special lipid profiles are associated with insulin resis-
tance according to BMI in a general population. The
ability to identify who is non-obese or overweight
and who are insulin resistant could help health care
Table 4 Comparison of triglyceride/HDL cholesterol ratio and LDL cholesterol/ HDL cholesterol ratio for predicting of
insulin resistance (HOMA-IR§ > 2.5) of subjects categorized by body mass index
HOMA-IR§
Cut-off point Characteristics ≤2.5 >2.5 Sensitivity Specificity Positive LR Negative LR Accuracy
Body mass index† < 25.0 kg/m
2 N = 980 N = 62 %
Triglycerides/HDL cholesterol ratio <1.50 580 20 0.67 0.59 1.63 0.56 59.7
Triglycerides/HDL cholesterol ratio ≥1.50 400 42
LDL cholesterol/HDL cholesterol ratio <2.14 682 19 0.69 0.70 2.30 0.44 69.6
LDL cholesterol/HDL cholesterol ratio ≥2.14 298 43
Body mass index† ≥ 25.0 kg/m
2 N = 245 N = 106
Triglycerides/HDL cholesterol ratio <2.20 157 45 0.57 0.64 1.58 0.67 62.1
Triglycerides/HDL cholesterol ratio ≥2.20 88 61
LDL cholesterol/HDL cholesterol ratio <2.25 143 49 0.59 0.58 1.40 0.71 57.0
LDL cholesterol/HDL cholesterol ratio ≥2.25 102 57
HOMA-IR, homeostasis of minimal assessment of insulin resistance; LR, likelihood ratio; HDL, high-density lipoprotein; LDL, low-density lipoprotein. §HOMA-IR was
calculated using the following formula; (fasting blood glucose (mg/dL) X immunoreactive insulin (mU/mL))/405.
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Page 5 of 6professionals in bringing about lifestyle interventions. In
that context, use of the cutoff-points of LDL-C/HDL-C
ratio or TG/HDL-C ratio described in this report is sim-
ple and useful. The present data documented that insu-
lin resistance was present even in subjects with BMI
within the normal range. Further prospective popula-
tion-based studies are needed to investigate the changes
in lipid metabolism by lifestyle interventions.
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